PRIME DISTRIBUTORS,MUMBAI vs. INCOME TAX OFFICER, MUMBAI
In favour of the assessee: the assessee's appeal was allowed. From the AI summary of this appeal.
What did the Tribunal hold?
The Tribunal held that the commission expenditure was intrinsically linked to the commission income earned from pharmaceutical companies, not the direct sales to government hospitals. The assessee provided sufficient evidence, including TDS and banking channel payments, to substantiate the genuineness and business purpose of the expenditure.
What were the facts?
The Assessing Officer disallowed commission expenditure of Rs. 37,68,000/- claimed by the assessee, believing it was related to sales to government hospitals. The assessee argued the commission was paid to agents for procuring business from pharmaceutical companies, not for direct sales.
What were the issues?
Whether the commission expenditure was genuinely incurred for the purpose of business and had a nexus with the income earned, or if it was erroneously linked to sales to government hospitals.
Which sections of the Income-tax Act were involved?
AI-generated summary — verify with the full judgment below
Income Tax Appellate Tribunal, “C” BENCH, MUMBAI
Before: SHRI CHALLA NAGENDRA PRASAD & SHRI G. M. DOSS
आदेश / ORDER
PER G.M. DOSS, ACCOUNTANT MEMBER : This appeal has been preferred by the assessee against the order dated 10.11.2025 passed by the Learned Commissioner of Income Tax (Appeals), National Faceless Appeal Centre (NFAC), Delhi, under section 250 of the Income-tax Act, 1961 ("the Act") for the Assessment Year 2020-21.
Briefly stated, the facts of the case are that, the dispute pertains to the disallowance of commission expenditure amounting to Rs.37,68,000/-. During the assessment proceedings, the Assessing Officer ("AO") observed that the assessee had claimed commission expenditure of Rs.37,68,000/- while declaring sales of Rs.1,41,17,484/-. The assessee is engaged in the business of trading/reselling pharmaceutical and cosmetic products. The AO noted that the sales were effected primarily to various Government hospitals situated in Mumbai and other parts of the State of Maharashtra. According to the AO, the assessee failed to furnish documentary evidence such as agreements, contracts, correspondence, or any other material demonstrating the nature of services rendered by the commission agents. The AO further observed that procurement by Government hospitals is ordinarily carried out through a tendering process, wherein the involvement of intermediaries or commission agents is generally not envisaged. Proceeding on this premise, the AO concluded that the commission expenditure had not been substantiated and accordingly disallowed the entire amount of Rs.37,68,000/-.
Aggrieved by the assessment order, the assessee carried the matter in appeal before the Learned CIT(A). It was contended that the impugned commission expenditure was not incurred in relation to the sales effected by the assessee to Government hospitals, but represented commission paid to various persons for facilitating commission-based business procured by the assessee from different pharmaceutical companies. The Learned CIT(A), however, was not convinced with the explanation furnished. According to the Learned CIT(A), the explanation did not accord with the business pattern reflected in the financial statements and the assessee had failed to establish a direct nexus between the commission payments and the corresponding commission income earned. The Learned CIT(A) further held that deduction of tax at source and payment through banking channels, by themselves, do not conclusively establish the genuineness or business expediency of the expenditure. The Learned CIT(A) also observed that the expenditure of Rs.37,68,000/- appeared disproportionately high having regard to the scale of operations and the commission income disclosed. Accordingly, the disallowance made by the AO was confirmed.
During the course of hearing before us, the Learned Authorised Representative ("Ld. AR") invited our attention to the Profit and Loss Account placed in the paper book. It was submitted that the assessee had disclosed commission income of Rs.61,55,857/- and commission expenditure of Rs.37,68,000/-, both of which formed part of the regular books of account.
The details of commission income received during the Financial Year 2019- 20 relevant to Assessment Year 2020-21 are as under:
Sr. Commission Received Name of the Party No. (Rs.) 1 Intas Pharmaceuticals Limited 1,39,305 2 Maan Pharmaceuticals Ltd. 6,25,287 3 Tablets India Limited 13,74,824 Mody Surgical Co. (Kashyap Pravin 4 58,701 Mody) 5 Rahul Pharma 13,65,700 6 LG Chem Life Science Pvt. Ltd. 4,99,145 7 MSD Pharmaceuticals Private Ltd. 7,69,400 8 Glenmark Pharmaceuticals Ltd. 13,23,495 Total 61,55,857
The corresponding commission paid by the assessee to various agents is as under:
Sr. No. Sales Person / Agent Commission Paid (Rs.) 1 Tejas Shah 4,00,000 2 Amish Maniar 75,000 3 Sagar Vanzara 3,00,000 Sr. No. Sales Person / Agent Commission Paid (Rs.) 4 Amish Maniar 25,000 5 Darshan Shah / Kirtikumar Shah 7,50,000 6 Montu Kapadia 10,18,000 7 Tejas Shah / Jigna Shah 9,00,000 8 Amit Kapadia HUF / Sameer Shah HUF 3,00,000 Total 37,68,000
The Ld. AR submitted that the commission income was earned by the assessee from the aforesaid pharmaceutical companies for facilitating sales of their products. In order to obtain such business and facilitate the execution of these transactions, the assessee had engaged various agents and paid commission to them. Thus, the commission expenditure was incurred wholly and exclusively for earning the commission income received from the above mentioned companies. It was emphatically contended that the commission expenditure had no nexus whatsoever with the direct sales of Rs.1,41,17,484/- effected by the assessee to Government hospitals. The entire premise adopted by the AO proceeded on an erroneous assumption that the commission was paid in relation to Government procurement contracts. In reality, the commission payments were made to agents who procured business from the pharmaceutical companies, enabling the assessee to earn commission income.
The Ld. AR further drew our attention to the documentary evidence placed on record, including the details of the income-tax returns filed by the respective commission recipients, wherein the commission received from the assessee had been duly disclosed as taxable income. It was also pointed out that tax had been deducted at source on the impugned payments and the payments had been made through normal banking channels. It was submitted that all these evidences had already been furnished before the lower authorities and no fresh evidence was being relied upon before the Tribunal.
We have carefully considered the rival submissions and perused the material available on record. From the financial statements and documentary evidence placed before us, it is evident that the assessee has disclosed commission income of Rs.61,55,857/- received from various pharmaceutical companies. The explanation consistently advanced by the assessee is that these companies had engaged the assessee to facilitate the marketing and sale of their products and, in turn, the assessee engaged different agents for procuring such business. Consequently, a part of the commission income earned by the assessee was passed on to such agents in the form of commission expenditure.
In our considered opinion, the AO proceeded on an incorrect factual premise by assuming that the commission expenditure was incurred in connection with the assessee's direct sales to Government hospitals. Once it is demonstrated from the books of account that the commission expenditure is intrinsically linked with the commission income earned from third party pharmaceutical companies and not with the direct sales reflected in the trading account, the very foundation of the disallowance ceases to survive.
We further note that the assessee has furnished the names of the commission recipients, details of tax deducted at source, proof of payment through banking channels, and copies of the income-tax returns of the recipients showing disclosure of the commission income. These evidences lend substantial corroboration to the genuineness of the transactions. Although deduction of tax at source or payment through banking channels may not, by themselves, conclusively establish the allowability of an expenditure, they nevertheless constitute relevant corroborative evidence when considered in conjunction with the surrounding facts and the overall business arrangement.
The Revenue has not brought on record any material to demonstrate that the commission payments were fictitious, that the recipients were non-existent, or that the payments had reverted to the assessee in any manner. Nor has any enquiry been conducted to controvert the evidence produced by the assessee. The disallowance rests solely on an erroneous understanding of the nature of the transactions.
Having regard to the totality of the facts and circumstances of the case, we are satisfied that the commission expenditure of Rs.37,68,000/- was incurred wholly and exclusively for the purposes of the assessee's business and bears a direct nexus with the commission income earned by the assessee. The assessee has discharged the burden cast upon it under section 37(1) of the Act by establishing the identity of the recipients, the genuineness of the payments, and the business purpose for which the expenditure was incurred.
Accordingly, we set aside the order of the Learned CIT(A) and direct the AO to delete the disallowance of Rs.37,68,000/-.
In the result, the appeal filed by the assessee is allowed.
Order pronounced on 07.08.2026
Sd/- Sd/-
Sd/- Sd/- CHALLA NAGENDRA PRASAD G. M. DOSS JUDICIAL MEMBER ACCOUNTANT MEMBER
Mumbai, Dated: 07/08/2026. Aditi Pandare, PS
Copy to: The Appellant The Respondent The CIT Concerned The DR, ITAT; and Guard file //True Copy//
By Order
Dy/Asstt. Registrar, ITAT, Mumbai
More judgments on Section 37(1)
- Gillette India Limited, Mumbai vs Principal Commissioner of Income Tax, JaipurITA 1316/JPR/2026[2018-19]Status: Disposed16 Oct 2026AY 2018-19
- Smit Navnitlal Soni, Ahmedabad, Gujarat vs ITO Ward-5(3)(1), Ahmedabad, GujaratITA 1434/AHD/2026[2021-22]Status: Disposed16 Oct 2026AY 2021-22
- Shobha Sudamrao Tagad, Ahmednagar vs ITO WD-1, AhmednagarITA 311/PUN/2026[2023-24]Status: Disposed13 Oct 2026AY 2023-24
- Digjam Limited, Jamnagar vs The Principal Commissioner of Income Tax…ITA 349/RJT/2025[2021-22]Status: Disposed12 Oct 2026AY 2021-22
- Rajesh Maru, Mhow vs ITO-5(1), IndoreITA 839/IND/2025[2023-2024]Status: Disposed12 Oct 2026AY 2023-2024
Recent GST High Court judgments
Search GST case law →- The State Of Bihar Through The Commissioner Of State Tax vs. Kaushlendra KumarPatna · 27 Oct 2026
- Ayush Sureshchandra Shah vs. State Of GujaratGujarat · 27 Oct 2026
- Sureshchandra Moolchand Shah vs. State Of GujaratGujarat · 27 Oct 2026
- M/S Larsen And Toubro Limited vs. Joint Commissioner Of Central GST And Anr.Delhi · 27 Oct 2026
- T C Global INDIA Private Limited vs. Principal Commissioner Of Central GST, North DelhiDelhi · 27 Oct 2026